Skip to content

Bayer – “Meet the Expert” session: Breaking the Cycle of Repeated Heart Failure Hospitalisations: An Emerging Treatment Strategy

Room:

Synergy Auditorium 2

Facilitator:

Abstract:

Speakers: 

Johann Bauersachs, MD, PhD (Chair)

Cardiology and Angiology Department
MH Hannover, Germany






Lorenz Van der Linden

Hospital Pharmacy Department
UZ Leuven, Belgium

 

 

 

 

 

Learning Objectives:

At the end of this session, the participants should:

  • Understand the unmet need for patients with worsening HF and the importance of reducing future HF hospitalisations

  • Be able to explain current treatment options for patients with HF following a worsening event and the limitation of these treatments

  • Understand the high-risk patient population in VICTORIA and the use of vericiguat for patients with symptomatic chronic HF following a worsening event

  • Understand the practical aspects of hospital treatment for patients with worsening HF

Educational need addressed:
Hospital pharmacists need to be aware of the recent results of the VICTORIA for high-risk chronic patients with worsening heart failure. They should know how to treat these patients in the context of current and future treatment options to ensure state-of-the-art medication in their respective hospitals to facilitate safe and efficient treatment for patients with CHF following a worsening event.

  

For further questions

×

Deadline extended to July 15th

Problems caused by shortages are serious, threaten patient care and require urgent action.

Help us provide an overview of the scale of the problem, as well as insights into the impact on overall patient care.

Our aim is to investigate the causes of medicine and medical device shortages in the hospital setting,  while also gathering effective solutions and best practices implemented at local, regional, and national levels.

×

Join us in Prague for the 2nd edition of BOOST!

Secure your spot in the Movement for Shortage-Free World

BOOST is where visionaries, innovators, and healthcare leaders come together to tackle one of the biggest challenges in hospital pharmacy—medicine shortages.